DrugMonitor™ Anti-Elotuzumab Antibody (VS-1224-YC413)
CAT#: VS-1224-YC413
Elotuzumab is a humanized IgG1 monoclonal antibody indicated for use with lenalidomide and dexamethasone in multiple myeloma treatment. The DrugMonitor™ Anti-Elotuzumab Antibody (VS-1224-YC413) is an anti-drug antibody (ADA) against Elotuzumab. This drug-based antibody is raised in mice immunized with the Elotuzumab. The anti-Elotuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Elotuzumab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Elotuzumab
- Target
- Elotuzumab
- Immunogen
- Elotuzumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Elotuzumab
- Drug Weight
- 148100.0 Da
- Formula
- C₆₄₇₆H₉₉₈₂N₁₇₁₄O₂₀₁₆S₄₂
- Related Disease
- Multiple myeloma treatment
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC413. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "elotuzumab"
Anti-SLAMF7 Recombinant Antibody (Elotuzumab)Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
Afuco™ Anti-SLAMF7 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-743)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. It is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IHC, FuncS, Inhib, Cyt
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC
Application: ELISA, FuncS, IHC, IF, FC, ADCC
Application: ELISA, PD, Activ, PK, Stim
Application: FC
Application: ELISA, FC, FuncS
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
